Kenneth L. Davis
Vice-Chair
Kenneth Davis is president and chief executive officer of the Mount Sinai Medical Center, and was dean of the Mount Sinai School of Medicine from 2003–2007. Under his leadership, Mount Sinai entered a new era of innovation in research, education, and clinical care. The Medical Center grew in both scope and ambition, accelerating the pace of scientific discovery and strengthening interdisciplinary collaboration.
He joined the faculty at Mount Sinai in 1979, becoming Chief of Psychiatry at the Bronx Veterans Administration Medical Center, and later rose to chair of the Department of Psychiatry at Mount Sinai School of Medicine in 1987. At Mount Sinai, Dr. Davis spearheaded research investigating the biology of neuropsychiatric disease. From 1984 to 2002, he directed Mount Sinai's Alzheimer's Disease Research Center. He also directed the National Institute of Mental Health-funded Silvio O. Conte Center for the Neurosciences of Mental Disorders.
The author or coauthor of hundreds of scientific articles, he is also the recipient of numerous awards from several prestigious organizations, including the Society of Biological Psychiatry, the American College of Neuropsychopharmacology, the Alzheimer's Association, the American Psychiatric Association, and the National Association for Mental Illness. In 2001 he was elected to membership in the Institute of Medicine of the National Academy of Sciences.
Among his leadership positions, he has been president of the American College of Neuropsychopharmacology; chair of the Board of Governors for the Greater New York Hospital Association; chair of the Board of Directors at the League of Voluntary Hospitals and Homes of New York; and chair of the New York Academy of Medicine Deans Council. In 2006 he was elected a trustee of the New York Academy of Medicine, where he is now secretary of the board.
He received a bachelor's degree magna cum laude from Yale College. He earned his medical degree from Mount Sinai School of Medicine, where he was valedictorian, and then completed his postdoctoral training in psychiatry and pharmacology at Stanford University Medical Center.